Jason Aryeh
About Jason Aryeh
Jason Aryeh is a Director at Ligand Pharmaceuticals and has held this position since 2006. He also serves on various committees for multiple companies, including Anebulo Pharmaceuticals and Orchestra BioMed, and has a strong background in economics and renewable energy.
Work at Ligand Pharmaceuticals
Jason Aryeh has held the position of Director at Ligand Pharmaceuticals since 2006, contributing to the company for 18 years in San Diego, CA. In his role, he serves as Chairman of the Nominating & Governance Committee and is a member of the Compensation Committee. His long-standing tenure at Ligand Pharmaceuticals highlights his commitment to the organization and its strategic initiatives.
Board Memberships and Leadership Roles
In addition to his role at Ligand Pharmaceuticals, Jason Aryeh serves as a Board Member at Great Product since 2021. He holds the position of Chairman of the Audit and Nominating & Governance Committees at Anebulo Pharmaceuticals and is also a member of the Audit Committee at Orchestra BioMed. His leadership in these roles reflects his extensive experience in corporate governance and oversight.
Education and Expertise
Jason Aryeh earned a B.A. in economics, with honors, from Colgate University. He is a member of the Omicron Delta Epsilon Honor Society in economics, which recognizes his academic excellence in the field. His educational background provides a strong foundation for his roles in finance and governance within the life sciences sector.
Background in Renewable Energy
In 2009, Jason Aryeh founded Rio Grande Solar and Rio Grande Renewables, LLC, where he has served as Chairman since its inception. This renewable energy company reflects his commitment to sustainable practices and innovation in energy solutions. His involvement in this sector complements his extensive experience in life sciences and biotechnology.
Experience in Life Sciences and Investment
Jason Aryeh has served as chairman of the board, on the board of directors, or as a consultant to numerous public and private life sciences companies and charitable foundations. He is also the Founder and Managing General Partner of JALAA Equities, LP, a private investment fund focused on the biotechnology and medical device sectors. His diverse experience underscores his expertise in both investment and the life sciences industry.